Thalassemia burden study for children and teens
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at the physical, emotional, and financial challenges faced by children and teens with thalassemia in Sohag, Egypt. Participation involves regular follow-up at a specific clinic and answering questions about your experiences, which may help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 18 years old
- You have been diagnosed with thalassemia
- You get regular care at a participating pediatric hematology clinic or thalassemia unit in Sohag
- You do not have other blood disorders unrelated to thalassemia
- You are not seriously ill at the time of the study
- You and your caregiver agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how severe thalassemia is in children and teens. It may help doctors understand the condition better and improve care.
This study looks at how blood transfusions for thalassemia may affect the reproductive system (gonads) in teenagers. It aims to find out if there are any issues so they can be managed early.
This study looks at how blood transfusions and thalassemia affect body composition (like muscle and fat) in children. It may help doctors understand and manage growth and nutrition better.
This trial tests a new gene therapy (BD211) for children and teens with severe beta-thalassemia who need regular blood transfusions. The treatment uses your own blood stem cells, modified with a working gene, to help your body make healthy red blood cells and reduce the need for transfusions.
This study tests a medicine called luspatercept to see if it safely helps children with beta-thalassemia need fewer blood transfusions or keep their hemoglobin levels stable. It is for children aged 6 to 17 who either get regular transfusions or have low hemoglobin and few transfusions.
This study tests a special system (Hemanext One) that stores red blood cells with less oxygen, to see if it helps people with thalassemia who need regular transfusions. It may reduce side effects or improve how well the transfusions work.
Hear when a new Thalassemia Particularly Transfusion Dependent Thalassemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.